Advertisement
Home Blog Page 1332

Sacubitril-Valsartan Does Not Cut Risk for Death, Heart Failure After MI

0

Sacubitril-valsartan not linked to reduced incidence of death from cardiovascular causes or incident heart failure versus ramipril

Risk for Incident Dementia Up With Pro-Inflammatory Diet

0

Individuals in highest versus lowest diet inflammatory index tertile were three times more likely to develop dementia

Many Psychiatric Patients Are Getting Risky Drug Gabapentin ‘Off-Label’

0
By Amy Norton HealthDay Reporter MONDAY, Nov. 22, 2021 (HealthDay News) -- Most prescriptions for the medication gabapentin are for unapproved uses -- and many...

New Review Claims First COVID-19 Patient Was Wuhan Market Vendor

0

While paper will rekindle debate over whether the pandemic resulted from animal-to-human transfer, it likely will not settle the issue

FDA Approves Both Pfizer, Moderna Boosters for All Adults

0

Any adult who received a second dose of either vaccine at least six months earlier should be able to get a booster as soon as this weekend

Vials Found in Lab Contained Vaccine, Not Smallpox Virus: CDC

0

Federal officials were alerted that the vials were found by a laboratory worker while cleaning out a freezer in the facility

Concern About School Shootings Tied to Anxiety, Panic in U.S. Teens

0

Associations for depressive symptoms vary by race/ethnicity

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

AHA: Oral Milvexian Promising for Prevention of VTE

0

In patients undergoing knee arthroplasty, postoperative incidence of venous thromboembolism lower with milvexian versus enoxaparin